Intensity Therapeutics, Inc.

US$3.00As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:INTSHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (68.73%)
Div yield —
ROE (161.84%)
Biotechnology
Beta (5Y) 3.04
PE TTM —
TSR TTM (83.57%)
Mkt cap US$9.795M
ROIC (102.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.87
28.87%
(95.75%)
Buy 9|8|3|6|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.04
0.05
0.05
14.52%
5.36%
12.49%
11.80%
Revenue$M
0.794
0.776
0.783
0.811
8.07%
4.36%
7.30%
7.80%
Peers (US$9.795M)
Cap (US$)
PE
9.890M
—
9.421M
—
Capital
TTM
5Y
10Y
Leveragex
1.208
0.532
0.552
EBIT/Intx
1.801
0.143
0.172
Own earn%
(296.75)
(15.69)
(21.37)
Sh yield%
30.81
31.78
31.85
Owners
Insiders/Inst%
7.34
63.79
Short interest%
4.04
SBC / revenue%
2.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
8–14
$1 testx
0.0
Incr. ROIC%
11